{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:52:31Z","timestamp":1774702351972,"version":"3.50.1"},"reference-count":128,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Skin diseases such as atopic dermatitis affect babies, children, and adults and are characterized\nby red skin\/spots, severe itching that appears on the face, head, legs, neck, and hands, and various\ncauses of illness caused by various external and internal factors. AD is a type IIgE-mediated hypersensitivity\nreaction. Herbal preparations treat various dermatological diseases like dry skin, melasma, acne,\nand eczema. Cosmeceuticals are the connection between cosmetics and medicine, one of the world's\nmost used forms of medicine. Cosmeceuticals products are beneficial in treating AD. Herbal cosmetics\nplay a major role in curing various skin diseases. Today, various herbs used in cosmeceuticals have\nanti-inflammatory, antioxidant, antibacterial, and antiseptic effects. Compared to synthetic preparations,\nherbal preparations have fewer side effects. This review paper introduces Atopic dermatitis, cosmeceutical,\nand various phytoconstituents like gallic acid, ferulic acid, boswellic acid, quercetin, and\nnaringenin tetra hydroxyl flavanol glycoside, glycyrrhizic acid, epigallocatechin gallate, etc., used in\natopic dermatitis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201820666230512110344","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T05:56:12Z","timestamp":1684130172000},"page":"312-325","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Review of Anti-Inflammatory Phytoconstituents Used in Herbal\nCosmeceuticals for the Treatment of Atopic Dermatitis"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-0747","authenticated-orcid":true,"given":"Purushottam","family":"Gangane","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, MS, 440037, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7205-2315","authenticated-orcid":true,"given":"Vidhi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, MS, 440037, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5626-4262","authenticated-orcid":true,"given":"Mokshada","family":"Selokar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, MS, 440037, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipali","family":"Vidhate","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, MS, 440037, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-5299","authenticated-orcid":true,"given":"Kapil","family":"Pawar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, MS, 440037, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-0769","authenticated-orcid":true,"given":"Nilesh","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Dadasaheb Balpande College of Pharmacy, Nagpur, MS, 440037, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","volume":"361","author":"Leung D.Y.M.","year":"2003","unstructured":"Leung D.Y.M.; Bieber T.; Atopic dermatitis. Lancet 2003,361(9352),151-160","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1016\/j.jaci.2003.09.032","volume":"112","author":"Novak N.","year":"2003","unstructured":"Novak N.; Bieber T.; Leung D.Y.; Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003,112(6),S128-S139","journal-title":"J Allergy Clin Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8561(03)00066-3","volume":"22","author":"Larsen F.S.","year":"2002","unstructured":"Larsen F.S.; Hanifin J.M.; Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002,22(1),1-24","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1468-3083.2006.01580.x","volume":"20","author":"M\u00f6hrenschlager M.","year":"2006","unstructured":"M\u00f6hrenschlager M.; Darsow U.; Schnopp C.; Ring J.; Atopic eczema: what\u2019s new? J Eur Acad Dermatol Venereol 2006,20(5),503-513","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=5","first-page":"108","volume":"50","author":"F\u00f6lster-Holst R.","year":"1999","unstructured":"F\u00f6lster-Holst R.; Steinsland K.; Lange I.; Christophers E.; Verlauf des eczema infantum. Hautarzt 1999,50(Suppl. 1),108","journal-title":"Hautarzt"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","volume":"118","author":"Akdis C.A.","year":"2006","unstructured":"Akdis C.A.; Akdis M.; Bieber T.; Bindslev-Jensen C.; Boguniewicz M.; Eigenmann P.; Hamid Q.; Kapp A.; Leung D.Y.M.; Lipozencic J.; Luger T.A.; Muraro A.; Novak N.; Platts-Mills T.A.; Rosenwasser L.; Scheynius A.; Simons F.E.; Spergel J.; Turjanmaa K.; Wahn U.; Weidinger S.; Werfel T.; Zuberbier T.; Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report. J Allergy Clin Immunol 2006,118(1),152-169","journal-title":"J Allergy Clin Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1067\/mai.2003.1595","volume":"112","author":"Novak N.","year":"2003","unstructured":"Novak N.; Bieber T.; Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003,112(2),252-262","journal-title":"J Allergy Clin Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","volume":"70","author":"Eichenfield L.F.","year":"2014","unstructured":"Eichenfield L.F.; Tom W.L.; Chamlin S.L.; Feldman S.R.; Hanifin J.M.; Simpson E.L.; Berger T.G.; Bergman J.N.; Cohen D.E.; Cooper K.D.; Cordoro K.M.; Davis D.M.; Krol A.; Margolis D.J.; Paller A.S.; Schwarzenberger K.; Silverman R.A.; Williams H.C.; Elmets C.A.; Block J.; Harrod C.G.; Smith Begolka W.; Sidbury R.; Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol 2014,70(2),338-351","journal-title":"J Am Acad Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","volume":"139","author":"Brunner P.M.","year":"2017","unstructured":"Brunner P.M.; Guttman-Yassky E.; Leung D.Y.M.; The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 2017,139(4),S65-S76","journal-title":"J Allergy Clin Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.jaci.2017.04.004","volume":"139","author":"Czarnowicki T.","year":"2017","unstructured":"Czarnowicki T.; Krueger J.G.; Guttman-Yassky E.; Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol 2017,139(6),1723-1734","journal-title":"J Allergy Clin Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","volume":"24","author":"Darsow U.","year":"2010","unstructured":"Darsow U.; Wollenberg A.; Simon D.; Ta\u00efeb A.; Werfel T.; Oranje A.; Gelmetti C.; Svensson A.; Deleuran M.; Calza A-M.; Giusti F.; L\u00fcbbe J.; Seidenari S.; Ring J.; ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010,24(3),317-328","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2017.01.027","volume":"140","author":"Guttman-Yassky E.","year":"2017","unstructured":"Guttman-Yassky E.; Ungar B.; Malik K.; Dickstein D.; Suprun M.; Estrada Y.D.; Xu H.; Peng X.; Oliva M.; Todd D.; Labuda T.; Suarez-Farinas M.; Bissonnette R.; Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis. J Allergy Clin Immunol 2017,140(4),1032-1042.e13","journal-title":"J Allergy Clin Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/jdv.12864","volume":"29","author":"Ng J.P.X.","year":"2015","unstructured":"Ng J.P.X.; Liew H.M.; Ang S.B.; Use of emollients in atopic dermatitis. J Eur Acad Dermatol Venereol 2015,29(5),854-857","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"Boguniewicz M.","year":"2011","unstructured":"Boguniewicz M.; Leung D.Y.M.; Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev 2011,242(1),233-246","journal-title":"Immunol Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"Palmer C.N.A.","year":"2006","unstructured":"Palmer C.N.A.; Irvine A.D.; Terron-Kwiatkowski A.; Zhao Y.; Liao H.; Lee S.P.; Goudie D.R.; Sandilands A.; Campbell L.E.; Smith F.J.D.; O\u2019Regan G.M.; Watson R.M.; Cecil J.E.; Bale S.J.; Compton J.G.; DiGiovanna J.J.; Fleckman P.; Lewis-Jones S.; Arseculeratne G.; Sergeant A.; Munro C.S.; El Houate B.; McElreavey K.; Halkjaer L.B.; Bisgaard H.; Mukhopadhyay S.; McLean W.H.I.; Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006,38(4),441-446","journal-title":"Nat Genet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra1011040","volume":"365","author":"Irvine A.D.","year":"2011","unstructured":"Irvine A.D.; McLean W.H.I.; Leung D.Y.M.; Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011,365(14),1315-1327","journal-title":"N Engl J Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","volume":"66","author":"Nutten S.","year":"2015","unstructured":"Nutten S.; Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015,66(Suppl. 1),8-16","journal-title":"Ann Nutr Metab"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2500\/aap2007.28.3041","volume":"28","author":"Thomsen S.F.","year":"2007","unstructured":"Thomsen S.F.; Ulrik C.S.; Kyvik K.O.; Hjelmborg J.V.; Skadhauge L.R.; Steffensen I.; Backer V.; Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy Asthma Proc 2007,28(5),535-539","journal-title":"Allergy Asthma Proc"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/08923973.2021.1889583","volume":"43","author":"Mandlik D.S.","year":"2021","unstructured":"Mandlik D.S.; Mandlik S.K.; Atopic dermatitis: New insight into the etiology, pathogenesis, diagnosis and novel treatment strategies. Immunopharmacol Immunotoxicol 2021,43(2),105-125","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1744666X.2016.1212660","volume":"13","author":"Kantor R.","year":"2017","unstructured":"Kantor R.; Silverberg J.I.; Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol 2017,13(1),15-26","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=21","first-page":"59","volume":"25","author":"Kasolang S.","year":"2020","unstructured":"Kasolang S.; Adlina W.A.; Rahman N.A.; Nik N.R.; Common skin disorders: A review. J Tribol 2020,25,59-82","journal-title":"J Tribol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"15184","DOI":"10.1111\/bph.15184","volume":"177","author":"Moniz T.","year":"2020","unstructured":"Moniz T.; Costa Lima S.A.; Reis S.; Human skin models: From healthy to disease\u2010mimetic systems; characteristics and applications. Br J Pharmacol 2020,177(19),15184","journal-title":"Br J Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","volume":"7","author":"Alkilani A.","year":"2015","unstructured":"Alkilani A.; McCrudden M.T.; Donnelly R.; Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015,7(4),438-470","journal-title":"Pharmaceutics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","volume":"43","author":"Proksch E.","year":"2006","unstructured":"Proksch E.; F\u00f6lster-Holst R.; Jensen J.M.; Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006,43(3),159-169","journal-title":"J Dermatol Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.clindermatol.2011.08.023","volume":"30","author":"Wolf R.","year":"2012","unstructured":"Wolf R.; Wolf D.; Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol 2012,30(3),329-334","journal-title":"Clin Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jaci.2017.01.008","volume":"139","author":"Bieber T.","year":"2017","unstructured":"Bieber T.; D\u2019Erme A.M.; Akdis C.A.; Traidl-Hoffmann C.; Lauener R.; Sch\u00e4ppi G.; Schmid-Grendelmeier P.; Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? J Allergy Clin Immunol 2017,139(4),S58-S64","journal-title":"J Allergy Clin Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1067\/mjd.2003.105","volume":"48","author":"Sator P.G.","year":"2003","unstructured":"Sator P.G.; Schmidt J.B.; H\u00f6nigsmann H.; Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003,48(3),352-358","journal-title":"J Am Acad Dermatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/1346-8138.15664","volume":"48","author":"Nakahara T.","year":"2021","unstructured":"Nakahara T.; Kido-Nakahara M.; Tsuji G.; Furue M.; Basics and recent advances in the pathophysiology of atopic dermatitis. J Dermatol 2021,48(2),130-139","journal-title":"J Dermatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3390\/ijms21082867","volume":"21","author":"Yang G.","year":"2020","unstructured":"Yang G.; Seok J.K.; Kang H.C.; Cho Y.Y.; Lee H.S.; Lee J.Y.; Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int J Mol Sci 2020,21(8),2867","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.16934","volume":"180","author":"Tsakok T.","year":"2019","unstructured":"Tsakok T.; Woolf R.; Smith C.H.; Weidinger S.; Flohr C.; Atopic dermatitis: The skin barrier and beyond. Br J Dermatol 2019,180(3),464-474","journal-title":"Br J Dermatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/bjd.15065","volume":"177","author":"Halling-Overgaard A.S.","year":"2017","unstructured":"Halling-Overgaard A.S.; Kezic S.; Jakasa I.; Engebretsen K.A.; Maibach H.; Thyssen J.P.; Skin absorption through atopic dermatitis skin: a systematic review. Br J Dermatol 2017,177(1),84-106","journal-title":"Br J Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4168\/aair.2014.6.4.276","volume":"6","author":"Lee H.J.","year":"2014","unstructured":"Lee H.J.; Lee S.H.; Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res 2014,6(4),276-287","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/bjd.13534","volume":"172","author":"Szegedi A.","year":"2015","unstructured":"Szegedi A.; Filaggrin mutations in early- and late-onset atopic dermatitis. Br J Dermatol 2015,172(2),320-321","journal-title":"Br J Dermatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jaci.2015.04.042","volume":"136","author":"Riethmuller C.","year":"2015","unstructured":"Riethmuller C.; McAleer M.A.; Koppes S.A.; Abdayem R.; Franz J.; Haftek M.; Campbell L.E.; MacCallum S.F.; McLean W.H.I.; Irvine A.D.; Kezic S.; Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis. J Allergy Clin Immunol 2015,136(6),1573-1580","journal-title":"J Allergy Clin Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/jid.2011.435","volume":"132","author":"De Benedetto A.","year":"2012","unstructured":"De Benedetto A.; Kubo A.; Beck L.A.; Skin barrier disruption: A requirement for allergen sensitization? J Invest Dermatol 2012,132(3),949-963","journal-title":"J Invest Dermatol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2006.04.042","volume":"118","author":"Cork M.J.","year":"2006","unstructured":"Cork M.J.; Robinson D.A.; Vasilopoulos Y.; Ferguson A.; Moustafa M.; MacGowan A.; Duff G.W.; Ward S.J.; Tazi-Ahnini R.; New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene\u2013environment interactions. J Allergy Clin Immunol 2006,118(1),3-21","journal-title":"J Allergy Clin Immunol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/000155500750042943","volume":"80","author":"Eberlein-K\u00f6nig B.","year":"2000","unstructured":"Eberlein-K\u00f6nig B.; Sch\u00e4fer T.; Huss-Marp J.; Darsow U.; M\u00f6hrenschlager M.; Herbert O.; Abeck D.; Kr\u00e4mer U.; Behrendt H.; Ring J.; Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol 2000,80(3),188-191","journal-title":"Acta Derm Venereol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2133.1987.tb05873.x","volume":"116","author":"White M.I.","year":"1987","unstructured":"White M.I.; Jenkinson D.M.; Lloyd D.H.; The effect of washing on the thickness of the stratum corneum in normal and atopic individuals. Br J Dermatol 1987,116(4),525-530","journal-title":"Br J Dermatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11882-009-0037-y","volume":"9","author":"Elias P.M.","year":"2009","unstructured":"Elias P.M.; Schmuth M.; Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009,9(4),265-272","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1046\/j.1523-1747.2002.00589.x","volume":"119","author":"Sato J.","year":"2002","unstructured":"Sato J.; Denda M.; Chang S.; Elias P.M.; Feingold K.R.; Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol 2002,119(4),900-904","journal-title":"J Invest Dermatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2133.1984.tb06606.x","volume":"111","author":"Al-Jaberi H.","year":"1984","unstructured":"Al-Jaberi H.; Marks R.; Studies of the clinically uninvolved skin in patients with dermatitis. Br J Dermatol 1984,111(4),437-443","journal-title":"Br J Dermatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2133.1992.tb00449.x","volume":"127","author":"Colloff M.J.","year":"1992","unstructured":"Colloff M.J.; Exposure to house dust mites in homes of people with atopic dermatitis. Br J Dermatol 1992,127(4),322-327","journal-title":"Br J Dermatol"},{"key":"ref=43","first-page":"1","volume":"4","author":"Singhal M.","year":"2011","unstructured":"Singhal M.; Khanna S.; Nasa A.T.; Cosmeceuticals for the skin: an overview. Asian J Pharm Clin Res 2011,4(2),1-6","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=44","first-page":"774","volume":"3","author":"Chaudhari P.M.","year":"2011","unstructured":"Chaudhari P.M.; Kawade P.V.; Funne S.M.; Cosmeceuticals-A review. Pharm Technol Int 2011,3,774-798","journal-title":"Pharm Technol Int"},{"key":"ref=45","first-page":"549","volume":"62","author":"Li D.","year":"2011","unstructured":"Li D.; Wu Z.; Martini N.; Wen J.; Advanced carrier systems in cosmetics and cosmeceuticals: a review. J Cosmet Sci 2011,62(6),549-563","journal-title":"J Cosmet Sci"},{"key":"ref=46","first-page":"49","volume":"22","author":"Kurata Y.","year":"1994","unstructured":"Kurata Y.; New Raw materials and technologies in cosmetics: Properties and applications of plant extract complexes. Fragr J 1994,22(2),49-53","journal-title":"Fragr J"},{"key":"ref=47","first-page":"45","volume":"4","author":"Wanjari N.","year":"2015","unstructured":"Wanjari N.; Waghmare J.; A review on latest trend of cosmetics-cosmeceuticals. Int J Pharma Res Rev 2015,4,45-51","journal-title":"Int J Pharma Res Rev"},{"key":"ref=48","first-page":"59","volume":"3","author":"Saha R.","year":"2012","unstructured":"Saha R.; Cosmeceuticals and herbal drugs: Practical uses. Int J Pharma Sci 2012,3(1),59","journal-title":"Int J Pharma Sci"},{"key":"ref=49","first-page":"632","volume":"2","author":"Pandey S.","year":"2010","unstructured":"Pandey S.; Meshya N.; Viral D.; Herbs play an important role in the field of cosmetics. Int J Pharm Tech Res 2010,2(1),632-639","journal-title":"Int J Pharm Tech Res"},{"key":"ref=50","first-page":"24","volume":"1","author":"Gediya S.K.","year":"2011","unstructured":"Gediya S.K.; Mistry R.B.; Patel U.K.; Blessy M.; Jain H.N.; Herbal plants: Used as a cosmetics. J Nat Prod Plant Resour 2011,1(1),24-32","journal-title":"J Nat Prod Plant Resour"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/0253-7613.16211","volume":"37","author":"Dureja H.","year":"2005","unstructured":"Dureja H.; Kaushik D.; Gupta M.; Kumar V.; Lather V.; Cosmeceuticals: An emerging concept. Indian J Pharmacol 2005,37(3),155","journal-title":"Indian J Pharmacol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","volume":"36","author":"Saeki H.","year":"2009","unstructured":"Saeki H.; Furue M.; Furukawa F.; Hide M.; Ohtsuki M.; Katayama I.; Sasaki R.; Suto H.; Takehara K.; Guidelines for management of atopic dermatitis. J Dermatol 2009,36(10),563-577","journal-title":"J Dermatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000096915","volume":"214","author":"Grimalt R.","year":"2007","unstructured":"Grimalt R.; Mengeaud V.; Cambazard F.; The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatol 2007,214(1),61-67","journal-title":"Dermatol"},{"key":"ref=54","first-page":"1512","volume":"3","author":"Sharma P.","year":"2011","unstructured":"Sharma P.; Cosmeceuticals: Regulatory scenario in US. Europe and India Pharm Technol Int 2011,3,1512-1535","journal-title":"Europe and India Pharm Technol Int"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.22270\/ijist.v3i4.27","volume":"9","author":"Gupta R.K.","year":"2018","unstructured":"Gupta R.K.; Soni P.; Shrivastava J.; Rajput P.; Parashar S.; Cosmeceutical role of Medicinal plants\/Herbs: A Review on commercially available cosmetic ingredients. Int J Innovative Sci and Technol 2018,9,70-73","journal-title":"Int J Innovative Sci and Technol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1006\/bbrc.1998.9681","volume":"253","author":"Bourne L.C.","year":"1998","unstructured":"Bourne L.C.; Rice-Evans C.; Bioavailability of ferulic acid. Biochem Biophys Res Commun 1998,253(2),222-227","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5507\/bp.2003.019","volume":"147","author":"Svobodov\u00e1 A.","year":"2003","unstructured":"Svobodov\u00e1 A.; Psotov\u00e1 J.; Walterov\u00e1 D.; Natural phenolics in the prevention of UV-induced skin damage. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003,147(2),137-145","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0891-5849(92)90184-I","volume":"13","author":"Graf E.","year":"1992","unstructured":"Graf E.; Antioxidant potential of ferulic acid. Free Radic Biol Med 1992,13(4),435-448","journal-title":"Free Radic Biol Med"},{"key":"ref=59","first-page":"321","volume":"53","author":"Bonina F.","year":"2002","unstructured":"Bonina F.; Puglia C.; Ventura D.; Aquino R.; Tortora S.; Sacchi A.; Saija A.; Tomaino A.; Pellegrino M.L.; de Caprariis P.; In vitro antioxidant and in vivo photoprotective effects of a lyophilized extract of Capparis spinosa L buds. J Cosmet Sci 2002,53(6),321-335","journal-title":"J Cosmet Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1021\/acs.biomac.5b00824","volume":"16","author":"Ouimet M.A.","year":"2015","unstructured":"Ouimet M.A.; Faig J.J.; Yu W.; Uhrich K.E.; Ferulic acid-based polymers with glycol functionality as a versatile platform for topical applications. Biomacromolecules 2015,16(9),2911-2919","journal-title":"Biomacromolecules"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.btre.2014.09.002","volume":"4","author":"Kumar N.","year":"2014","unstructured":"Kumar N.; Pruthi V.; Potential applications of ferulic acid from natural sources. Biotechnol Rep (Amst) 2014,4,86-93","journal-title":"Biotechnol Rep (Amst)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","volume":"12","author":"Das S.","year":"2011","unstructured":"Das S.; Chaudhury A.; Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011,12(1),62-76","journal-title":"AAPS PharmSciTech"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12247-021-09543-8","volume":"17","author":"Rezaeiroshan A.","year":"2022","unstructured":"Rezaeiroshan A.; Saeedi M.; Morteza-Semnani K.; Akbari J.; Hedayatizadeh-Omran A.; Goli H.; Nokhodchi A.; Vesicular formation of trans-ferulic acid: An efficient approach to improve the radical scavenging and antimicrobial properties. J Pharm Innov 2022,17(3),652-661","journal-title":"J Pharm Innov"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1038\/s41598-020-68732-6","volume":"10","author":"Das S.","year":"2020","unstructured":"Das S.; Wong A.B.H.; Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization. Sci Rep 2020,10(1),12288","journal-title":"Sci Rep"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"125857","DOI":"10.1016\/j.foodchem.2019.125857","volume":"310","author":"Pereira G.A.","year":"2020","unstructured":"Pereira G.A.; Arruda H.S.; de Morais D.R.; Peixoto Araujo N.M.; Pastore G.M.; Mutamba (Guazuma ulmifolia Lam.) fruit as a novel source of dietary fibre and phenolic compounds. Food Chem 2020,310,125857","journal-title":"Food Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"127266","DOI":"10.1016\/j.foodchem.2020.127266","volume":"330","author":"Dom\u00ednguez R.","year":"2020","unstructured":"Dom\u00ednguez R.; Zhang L.; Rocchetti G.; Lucini L.; Pateiro M.; Munekata P.E.S.; Lorenzo J.M.; Elderberry (Sambucus nigra L.) as potential source of antioxidants. Characterization, optimization of extraction parameters and bioactive properties. Food Chem 2020,330,127266","journal-title":"Food Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-020-01931-0","volume":"394","author":"Nouri A.","year":"2021","unstructured":"Nouri A.; Heibati F.; Heidarian E.; Gallic acid exerts anti-inflammatory, anti-oxidative stress, and nephroprotective effects against paraquat-induced renal injury in male rats. Naunyn Schmiedebergs Arch Pharmacol 2021,394(1),1-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2147\/CCID.S327825","volume":"14","author":"Hu G.","year":"2021","unstructured":"Hu G.; Zhou X.; Gallic acid ameliorates atopic dermatitis-like skin inflammation through immune regulation in a mouse model. Clin Cosmet Investig Dermatol 2021,14,1675-1683","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.fct.2010.06.024","volume":"48","author":"Ho H.H.","year":"2010","unstructured":"Ho H.H.; Chang C.S.; Ho W.C.; Liao S.Y.; Wu C.H.; Wang C.J.; Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-\u03baB activity and downregulation of PI3K\/AKT\/small GTPase signals. Food Chem Toxicol 2010,48(8-9),2508-2516","journal-title":"Food Chem Toxicol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.taap.2012.10.019","volume":"266","author":"Ho H.H.","year":"2013","unstructured":"Ho H.H.; Chang C.S.; Ho W.C.; Liao S.Y.; Lin W.L.; Wang C.J.; Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT\/small GTPase signals and inhibition of NF-\u03baB activity. Toxicol Appl Pharmacol 2013,266(1),76-85","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/13880209.2010.528432","volume":"49","author":"Manosroi A.","year":"2011","unstructured":"Manosroi A.; Jantrawut P.; Akazawa H.; Akihisa T.; Manosroi W.; Manosroi J.; Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls. Pharm Biol 2011,49(6),553-562","journal-title":"Pharm Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","volume":"67","author":"Nagle D.G.","year":"2006","unstructured":"Nagle D.G.; Ferreira D.; Zhou Y.D.; Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 2006,67(17),1849-1855","journal-title":"Phytochemistry"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/jdv.17710","volume":"36","author":"Braegelmann C.","year":"2022","unstructured":"Braegelmann C.; Niebel D.; Ferring-Schmitt S.; Fetter T.; Landsberg J.; H\u00f6lzel M.; Effern M.; Glodde N.; Steinbuch S.; Bieber T.; Wenzel J.; Epigallocatechin\u20103\u2010gallate exhibits anti\u2010inflammatory effects in a human interface dermatitis model-Implications for therapy. J Eur Acad Dermatol Venereol 2022,36(1),144-153","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=74","first-page":"68","volume":"14","author":"Mazyed E.A.","year":"2021","unstructured":"Mazyed E.A.; Helal D.A.; Elkhoudary M.M.; Abd Elhameed A.G.; Yasser M.; Formulation and optimization of nanospanlastics for improving the bioavailability of green tea epigallocatechin gallate. J Pharm 2021,14(1),68","journal-title":"J Pharm"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/jocd.12492","volume":"17","author":"Juh\u00e1sz M.L.W.","year":"2018","unstructured":"Juh\u00e1sz M.L.W.; Levin M.K.; Marmur E.S.; The use of natural ingredients in innovative Korean cosmeceuticals. J Cosmet Dermatol 2018,17(3),305-312","journal-title":"J Cosmet Dermatol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/ptr.6670","volume":"34","author":"Frasheri L.","year":"2020","unstructured":"Frasheri L.; Schielein M.C.; Tizek L.; Mikschl P.; Biedermann T.; Zink A.; Great green tea ingredient? A narrative literature review on epigallocatechin gallate and its biophysical properties for topical use in dermatology. Phytother Res 2020,34(9),2170-2179","journal-title":"Phytother Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2019.01.029","volume":"296","author":"Nagula R.L.","year":"2019","unstructured":"Nagula R.L.; Wairkar S.; Recent advances in topical delivery of flavonoids: A review. J Control Release 2019,296,190-201","journal-title":"J Control Release"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2016.02.039","volume":"502","author":"Fangueiro J.F.","year":"2016","unstructured":"Fangueiro J.F.; Calpena A.C.; Clares B.; Andreani T.; Egea M.A.; Veiga F.J.; Garcia M.L.; Silva A.M.; Souto E.B.; Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. Int J Pharm 2016,502(1-2),161-169","journal-title":"Int J Pharm"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2478\/acph-2014-0017","volume":"64","author":"Scalia S.","year":"2014","unstructured":"Scalia S.; Trotta V.; Bianchi, A In vivo human skin penetration of (\u2013)-epigallocatechin-3-gallate from topical formulations. Acta Pharm 2014,64(2),257-265","journal-title":"Acta Pharm"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10965-017-1342-0","volume":"24","author":"Drew V.J.","year":"2017","unstructured":"Drew V.J.; Huang H.Y.; Tsai Z.H.; Tsai H.H.; Tseng C.L.; Preparation of gelatin\/epigallocatechin gallate self-assembly nanoparticles for transdermal drug delivery. J Polym Res 2017,24(11),188","journal-title":"J Polym Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.actbio.2021.05.032","volume":"130","author":"Chiu Y.H.","year":"2021","unstructured":"Chiu Y.H.; Wu Y.W.; Hung J.I.; Chen M.C.; Epigallocatechin gallate\/L-ascorbic acid\u2013loaded poly-\u03b3-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis. Acta Biomater 2021,130,223-233","journal-title":"Acta Biomater"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.3390\/molecules25225453","volume":"25","author":"Shariare M.H.","year":"2020","unstructured":"Shariare M.H.; Afnan K.; Iqbal F.; Altamimi M.A.; Ahamad S.R.; Aldughaim M.S.; Alanazi F.K.; Kazi M.; Development and optimization of epigallocatechin-3-gallate (EGCG) nano phytosome using design of experiment (DoE) and their in vivo anti-inflammatory studies. MOLEFW 2020,25(22),5453","journal-title":"MOLEFW"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1934578X1300800335","DOI":"10.1177\/1934578X1300800335","volume":"8","author":"Ming LJ","year":"2013","unstructured":"Ming LJ; Yin AC; Therapeutic effects of glycyrrhizic acid. Natprod communications 2013,8(3),1934578X1300800335","journal-title":"Natprod communications"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/ics.12548","volume":"41","author":"Kowalska A.","year":"2019","unstructured":"Kowalska A.; Kalinowska-Lis U.; 18\u03b2-Glycyrrhetinic acid: Its core biological properties and dermatological applications. Int J Cosmet Sci 2019,41(4),325-331","journal-title":"Int J Cosmet Sci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-6121.1000143","volume":"4","author":"Sirikudta W.","year":"2013","unstructured":"Sirikudta W.; Kulthanan K.; Varothai S.; Nuchkull P.; Moisturizers for patients with atopic dermatitis: An overview. J Allergy Ther 2013,4(4),1-6","journal-title":"J Allergy Ther"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.clindermatol.2011.08.018","volume":"30","author":"Draelos Z.D.","year":"2012","unstructured":"Draelos Z.D.; New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams. Clin Dermatol 2012,30(3),345-348","journal-title":"Clin Dermatol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1248\/cpb.34.897","volume":"34","author":"Inoue H.","year":"1986","unstructured":"Inoue H.; Saito H.; Koshihara Y.; Murota S.I.; Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase. Chem Pharm Bull (Tokyo) 1986,34(2),897-901","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/00914037.2018.1443932","volume":"68","author":"Chauhan S.","year":"2019","unstructured":"Chauhan S.; Gulati N.; Nagaich U.; Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery. Int J Polym Mater 2019,68(5),266-277","journal-title":"Int J Polym Mater"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2100028","DOI":"10.1002\/adtp.202100028","volume":"4","author":"Barbosa A.I.","year":"2021","unstructured":"Barbosa A.I.; Torres T.; Lima S.A.C.; Reis S.; Hydrogels: A promising vehicle for the topical management of atopic dermatitis. Adv Ther (Weinh) 2021,4(7),2100028","journal-title":"Adv Ther (Weinh)"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"120762","DOI":"10.1016\/j.ijpharm.2021.120762","volume":"604","author":"Guo T.","year":"2021","unstructured":"Guo T.; Lu J.; Fan Y.; Zhang Y.; Yin S.; Sha X.; Feng N.; TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis. Int J Pharm 2021,604,120762","journal-title":"Int J Pharm"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41392-021-00733-x","volume":"6","author":"Zhou Y.W.","year":"2021","unstructured":"Zhou Y.W.; Xie Y.; Tang L.S.; Pu D.; Zhu Y.J.; Liu J.Y.; Ma X.L.; Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther 2021,6(1),317","journal-title":"Signal Transduct Target Ther"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.phymed.2007.11.019","volume":"15","author":"Singh S.","year":"2008","unstructured":"Singh S.; Khajuria A.; Taneja S.C.; Johri R.K.; Singh J.; Qazi G.N.; Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine 2008,15(6-7),400-407","journal-title":"Phytomedicine"},{"key":"ref=93","first-page":"24","volume":"23","author":"Das S.A.","year":"2018","unstructured":"Das S.A.; Mandal S.K.; Current developments on anti-inflammatory natural medicines. J Neurodegener Dis 2018,23,24","journal-title":"J Neurodegener Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-3-319-41334-1_13","author":"Ammon H.P.","year":"2016","unstructured":"Ammon H.P.;  Boswellic acids and their role in chronic inflammatory diseases 2016,291-327","journal-title":"Boswellic acids and their role in chronic inflammatory diseases"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1572-5995(00)80024-1","volume":"22","author":"R\u00edos J.L.","year":"2000","unstructured":"R\u00edos J.L.; Recio M.C.; Ma\u00e1\u00f1ez S.; Giner R.M.; Natural triterpenoids as anti-inflammatory agents. Studies in Natural Products Chemistry 2000,22,93-143","journal-title":"Studies in Natural Products Chemistry"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2174\/092986706779010333","volume":"13","author":"Poeckel D.","year":"2006","unstructured":"Poeckel D.; Werz O.; Boswellic acids: biological actions and molecular targets. Curr Med Chem 2006,13(28),3359-3369","journal-title":"Curr Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-3-642-55528-2_17","author":"Capasso F.","year":"2003","unstructured":"Capasso F.; Gaginella T.S.; Grandolini G.; Izzo A.A.; Anti-inflammatory Plants. Phytotherapy 2003,173-191","journal-title":"Phytotherapy"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1517\/13543776.13.4.489","volume":"13","author":"Gibbons S.","year":"2003","unstructured":"Gibbons S.; An overview of plant extracts as potential therapeutics. Expert Opin Ther Pat 2003,13(4),489-497","journal-title":"Expert Opin Ther Pat"},{"key":"ref=99","first-page":"321","volume":"7","author":"Togni S.","year":"2014","unstructured":"Togni S.; Maramaldi G.; Di Pierro F.; Biondi M.; A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis. Clin Cosmet Investig Dermatol 2014,7,321-327","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1211\/jpp.62.02.0016","volume":"62","author":"Goel A.","year":"2010","unstructured":"Goel A.; Ahmad F.J.; Singh R.M.; Singh G.N.; 3-Acetyl-11-keto-\u03b2-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. J Pharm Pharmacol 2010,62(2),273-278","journal-title":"J Pharm Pharmacol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3109\/10717544.2016.1149744","volume":"23","author":"Mehta M.","year":"2016","unstructured":"Mehta M.; Dureja H.; Garg M.; Development and optimization of boswellic acid-loaded proniosomal gel. Drug Deliv 2016,23(8),3072-3081","journal-title":"Drug Deliv"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3109\/10717544.2014.898347","volume":"22","author":"Mostafa D.M.","year":"2015","unstructured":"Mostafa D.M.; Ammar N.M.; Basha M.; Hussein R.A.; El Awdan S.; Awad G.; Transdermal microemulsions of Boswellia carterii Bird: Formulation, characterization and in vivo evaluation of anti-inflammatory activity. Drug Deliv 2015,22(6),748-756","journal-title":"Drug Deliv"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.09.030","volume":"402","author":"Kang M.J.","year":"2010","unstructured":"Kang M.J.; Eum J.Y.; Park S.H.; Kang M.H.; Park K.H.; Choi S.E.; Lee M.W.; Kang K.H.; Oh C.H.; Choi Y.W.; Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC\/Nga mice. Int J Pharm 2010,402(1-2),198-204","journal-title":"Int J Pharm"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"112066","DOI":"10.1016\/j.phytochem.2019.112066","volume":"166","author":"Sunil C.","year":"2019","unstructured":"Sunil C.; Xu B.; An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry 2019,166,112066","journal-title":"Phytochemistry"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"111741","DOI":"10.1016\/j.biopha.2021.111741","volume":"140","author":"Wu S.","year":"2021","unstructured":"Wu S.; Pang Y.; He Y.; Zhang X.; Peng L.; Guo J.; Zeng J.; A comprehensive review of natural products against atopic dermatitis: Flavonoids, alkaloids, terpenes, glycosides and other compounds. Biomed Pharmacother 2021,140,111741","journal-title":"Biomed Pharmacother"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1211\/jpp.60.11.0007","volume":"60","author":"Kim Y.J.","year":"2010","unstructured":"Kim Y.J.; Choi S.E.; Lee M.W.; Lee C.S.; Taxifolin glycoside inhibits dendritic cell responses stimulated by lipopolysaccharide and lipoteichoic acid. J Pharm Pharmacol 2010,60(11),1465-1472","journal-title":"J Pharm Pharmacol"},{"key":"ref=107","author":"Gupta V","unstructured":"Gupta V; Sanyogita K; Manigauha A;  Novel formulation of aloe\tvera and quercetin in the management of dermal disease: Eczema. Available from:"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu8030167","volume":"8","author":"Li Y.","year":"2016","unstructured":"Li Y.; Yao J.; Han C.; Yang J.; Chaudhry M.; Wang S.; Liu H.; Yin Y.; Quercetin, inflammation and immunity. Nutrients 2016,8(3),167","journal-title":"Nutrients"},{"key":"ref=109","author":"Hatahet T.","unstructured":"Hatahet T.; Comparison of topical quercetin nanoformulations for skin protection. Available from:"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0939-6411(03)00101-2","volume":"56","author":"Saija A.","year":"2003","unstructured":"Saija A.; Tomaino A.; Trombetta D.; Pellegrino M.L.; Tita B.; Messina C.; Bonina F.P.; Rocco C.; Nicolosi G.; Castelli F.; \u2018In vitro\u2019 antioxidant and photoprotective properties and interaction with model membranes of three new quercetin esters. Eur J Pharm Biopharm 2003,56(2),167-174","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/10715769900301141","volume":"31","author":"Hollman P.C.H.","year":"1999","unstructured":"Hollman P.C.H.; Bijsman M.N.C.P.; van Gameren Y.; Cnossen E.P.J.; de Vries J.H.M.; Katan M.B.; The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 1999,31(6),569-573","journal-title":"Free Radic Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1021\/jf0483669","volume":"53","author":"Rothwell J.A.","year":"2005","unstructured":"Rothwell J.A.; Day A.J.; Morgan M.R.A.; Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J Agric Food Chem 2005,53(11),4355-4360","journal-title":"J Agric Food Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1080\/01616412.2016.1240393","volume":"38","author":"Du G.","year":"2016","unstructured":"Du G.; Zhao Z.; Chen Y.; Li Z.; Tian Y.; Liu Z.; Liu B.; Song J.; Quercetin attenuates neuronal autophagy and apoptosis in rat traumatic brain injury model via activation of PI3K\/Akt signaling pathway. Neurol Res 2016,38(11),1012-1019","journal-title":"Neurol Res"},{"key":"ref=114","first-page":"47","volume":"20","author":"Shaik Y.B.","year":"2006","unstructured":"Shaik Y.B.; Castellani M.L.; Perrella A.; Conti F.; Salini V.; Tete S.; Madhappan B.; Vecchiet J.; De Lutiis M.A.; Caraffa A.; Cerulli G.; Role of quercetin (a natural herbal compound) in allergy and inflammation. J Biol Regul Homeost Agents 2006,20(3-4),47-52","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref=115","first-page":"959","volume":"31","author":"Caddeo C","year":"2014","unstructured":"Caddeo C; D\u00edez-Sales O; Pons R; Fern\u00e0ndez-Busquets X; Fadda AM; Manconi M; Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: In vivo and in vitro evaluation Pharmares 2014,31(4),959-68","journal-title":"Pharmares"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5530\/phrev.2021.15.4","volume":"15","author":"Mallya R.","year":"2021","unstructured":"Mallya R.; Patil K.; Recent developments in formulation design of a multifunctional phytochemical quercetin: A review. Pharmacogn Rev 2021,15,29","journal-title":"Pharmacogn Rev"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.drudis.2016.02.011","volume":"21","author":"Karuppagounder V.","year":"2016","unstructured":"Karuppagounder V.; Arumugam S.; Thandavarayan R.A.; Sreedhar R.; Giridharan V.V.; Watanabe K.; Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis. Drug Discov Today 2016,21(4),632-639","journal-title":"Drug Discov Today"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13596-017-0281-y","volume":"17","author":"Mehta P.","year":"2017","unstructured":"Mehta P.; Lohidasan S.; Mahadik K.R.; Pharmacokinetic behaviour of clinically important TCM prescriptions. Orient Pharm Exp Med 2017,17(3),171-188","journal-title":"Orient Pharm Exp Med"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"Article ID 7830367","DOI":"10.1155\/2016\/7830367","volume":"2016","author":"Mehta P.","year":"2016","unstructured":"Mehta P.; Dhapte V.; A comprehensive review on pharmacokinetic profile of some traditional Chinese medicines. New J Sci 2016,2016,Article ID 7830367","journal-title":"New J Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ph12010011","volume":"12","author":"Salehi B.","year":"2019","unstructured":"Salehi B.; Fokou P.; Sharifi-Rad M.; Zucca P.; Pezzani R.; Martins N.; Sharifi-Rad J.; The therapeutic potential of naringenin: A review of clinical trials. Pharmaceuticals (Basel) 2019,12(1),11","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lfs.2018.10.066","volume":"215","author":"Joshi R.","year":"2018","unstructured":"Joshi R.; Kulkarni Y.A.; Wairkar S.; Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life Sci 2018,215,43-56","journal-title":"Life Sci"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/acs.jnatprod.8b00366","volume":"82","author":"Escribano-Ferrer E.","year":"2019","unstructured":"Escribano-Ferrer E.; QueraltRegu\u00e9, J.; Garcia-Sala, X.; Boix Mon Raventos, RM. In vivo anti-inflammatory and antiallergic activity of pure naringenin, naringeninchalcone, and quercetin in mice. J Nat Prod 2019,82(2),177-182","journal-title":"J Nat Prod"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcatb.2007.10.011","volume":"52-53","author":"Ribeiro I.A.","year":"2008","unstructured":"Ribeiro I.A.; Rocha J.; Sepodes B.; Mota-Filipe H.; Ribeiro M.H.; Effect of naringin enzymatic hydrolysis towards naringenin on the anti-inflammatory activity of both compounds. J Mol Catal, B Enzym 2008,52-53,13-18","journal-title":"J Mol Catal, B Enzym"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1271\/bbb.68.1706","volume":"68","author":"Yamamoto T.","year":"2004","unstructured":"Yamamoto T.; Yoshimura M.; Yamaguchi F.; Kouchi T.; Tsuji R.; Saito M.; Obata A.; Kikuchi M.; Anti-allergic activity of naringenin chalcone from a tomato skin extract. Biosci Biotechnol Biochem 2004,68(8),1706-1711","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.lfs.2007.09.001","volume":"81","author":"Hirai S.","year":"2007","unstructured":"Hirai S.; Kim Y.I.I.; Goto T.; Kang M.S.; Yoshimura M.; Obata A.; Yu R.; Kawada T.; Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci 2007,81(16),1272-1279","journal-title":"Life Sci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/phpp.12335","volume":"34","author":"Joshi H.","year":"2018","unstructured":"Joshi H.; Hegde A.R.; Shetty P.K.; Gollavilli H.; Managuli R.S.; Kalthur G.; Mutalik S.; Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations. Photodermatol Photoimmunol Photomed 2018,34(1),69-81","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/0110-5558.72416","volume":"1","author":"Kaity S.","year":"2010","unstructured":"Kaity S.; Maiti S.; Ghosh A.; Pal D.; Ghosh A.; Banerjee S.; Microsponges: A novel strategy for drug delivery system. J Adv Pharm Technol Res 2010,1(3),283-290","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.colsurfb.2017.11.068","volume":"162","author":"Pleguezuelos-Villa M.","year":"2018","unstructured":"Pleguezuelos-Villa M.; Mir-Palomo S.; D\u00edez-Sales O.; Buso M.A.O.V.; Sauri A.R.; N\u00e1cher A.; A novel ultradeformable liposomes of Naringin for anti-inflammatory therapy. Colloids Surf B Biointerfaces 2018,162,265-270","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230512110344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216840\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230512110344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:22:23Z","timestamp":1700652143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216840\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666230512110344","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}